BridgeMD
Exploratory study on the impact of different doses and route of administration of exogenous progesterone in artificial endometrial preparation cycles on endometrial structure and function
EU CTIS ID: 2024-515811-22-00
What this study is testing
To compare the endometrial function (endometrial gene expression) according to the use of different types of exogenous progesterone available on the market depending on their doses and route of administration (vaginal, subcutaneous or intramuscular).
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- All women with no history of infertility who agree to participate in the study: 1. Informed consent form (ICF) dated and signed. 2. Age: 18-35 years old , both inclusive 3. Regular menstrual cycles (between 22 and 35 days) 4. In good health and not suffering from any mental or medical condition(s) that would preclude participation in the study
You likely can't join if
- Subjects who meet one or more of the following will not be considered eligible to participate in the pilot study: 1.Simultaneous participation in other clinical studies that, at the researcher's criteria, could interfere with the results of this study. 2.Taking contraceptives in the three months prior to signing informed consent. 3.Presence of uterine pathology (submucosal or intramural myomas >4 cm deforming cavity, endometrial polyps or müllerian anomalies) or adnexal pathology (communicating hydrosalpinx). 4.Background of thrombosis, breast cancer, systemic diseases. 5.Those unable to comprehend the investigational nature of the proposed study.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.